RWS
SUPN icon

Retirement Wealth Solutions’s Supernus Pharmaceuticals SUPN Stock Holding History

Retirement Wealth Solutions’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09K Sell
45
-10
-18% -$480 ﹤0.01% 518
2026
Q1 		$2.84K Buy
55
+9
+20% +$458 ﹤0.01% 427
2025
Q4 		$2.29K Buy
46
+18
+64% +$875 ﹤0.01% 434
2025
Q3 		$1.34K Buy
+28
New +$1.13K ﹤0.01% 509

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Retirement Wealth Solutions's SUPN Position: Q2 2026 in Review

Retirement Wealth Solutions reduced its Supernus Pharmaceuticals (SUPN) stake by 18% in Q2 2026, selling an estimated $480 and leaving 45 shares worth $2.09K. The position accounts for ﹤0.01% of the portfolio, ranked #518.

Retirement Wealth Solutions first reported a position in SUPN in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.84K in Q1 2026. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Retirement Wealth Solutions held 45 shares of Supernus Pharmaceuticals worth $2.09K as of Q2 2026.
  • Retirement Wealth Solutions sold 10 Supernus Pharmaceuticals shares in Q2 2026, an estimated $480.
  • Supernus Pharmaceuticals made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q2 2026, its #518 holding.
  • Retirement Wealth Solutions first reported a position in Supernus Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Retirement Wealth Solutions's Supernus Pharmaceuticals position peaked at $2.84K in Q1 2026.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Retirement Wealth Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.